{
    "title": "AstraZeneca drops plans for Covid jab approval in US",
    "url": "https://www.dailymail.co.uk/wires/pa/article-11412285/AstraZeneca-drops-plans-Covid-jab-approval-US.html",
    "date": "2022-11-10",
    "keywords": [
        "vaccine",
        "year",
        "astrazeneca",
        "approval",
        "jab",
        "use",
        "group",
        "application",
        "demand",
        "covid19",
        "fda",
        "booster",
        "quarter",
        "vaxzevria",
        "company",
        "world",
        "evusheld",
        "university",
        "thirdquarter",
        "food",
        "drug",
        "administration",
        "covid",
        "europe",
        "boss",
        "vaccination",
        "licence",
        "worldwide",
        "kirsty",
        "availability",
        "firm",
        "basis",
        "coronavirus",
        "treatment",
        "antibody",
        "therapy",
        "emergency",
        "december",
        "q3",
        "today",
        "benefit",
        "investment",
        "rd",
        "growth",
        "azn",
        "pictwittercombxsyisu034",
        "astrazenecas",
        "thursday",
        "outlook",
        "performance",
        "share",
        "percentage",
        "guidance",
        "increase",
        "farxiga",
        "tagrisso",
        "cancer"
    ],
    "category": [
        "wires",
        "pa"
    ]
}